M. Lehrke
Epidemiology · 2000–2008
A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 63 citations into it; #1,054 of 2,148 by trust here, #687 by citations
- Physiology — 48 citations into it; #865 of 2,276 by trust here, #676 by citations
- Cardiology and Cardiovascular Medicine — 13 citations into it
Whom M. Lehrke trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Lehrke overall
Papers from M. Lehrke's perspective
Ordered by how strongly the researchers M. Lehrke trusts endorse each paper. Same corpus, a different order for every researcher.
- Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* (Journal of Biological Chemistry)
- FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family (EMBO Journal)
- The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. (Diabetes)
- Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance (Proceedings of the National Academy of Sciences of the United States of America)
- PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway (Nature Medicine)
- Obesity-induced inflammatory changes in adipose tissue. (Journal of Clinical Investigation)
- A family of tissue-specific resistin-like molecules. (Proceedings of the National Academy of Sciences of the United States of America)
- Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. (Journal of Clinical Investigation)
- Combinatorial control of gene expression by nuclear receptors and coregulators. (Cell)
- Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα (Nature)
Their papers
- The many faces of PPARgamma. (2005) — 1,470 citations
- Adipokines and Insulin Resistance (2008) — 868 citations
- Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. (2005) — 901 citations
- Resistin Is an Inflammatory Marker of Atherosclerosis in Humans (2005) — 954 citations
- High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. (2000) — 847 citations